ATE366303T1 - Kristallines tnf-alpha-konvertierendes enzym und verwendung davon - Google Patents

Kristallines tnf-alpha-konvertierendes enzym und verwendung davon

Info

Publication number
ATE366303T1
ATE366303T1 AT99905615T AT99905615T ATE366303T1 AT E366303 T1 ATE366303 T1 AT E366303T1 AT 99905615 T AT99905615 T AT 99905615T AT 99905615 T AT99905615 T AT 99905615T AT E366303 T1 ATE366303 T1 AT E366303T1
Authority
AT
Austria
Prior art keywords
tnf
crystalline
converting enzyme
alpha converting
alpha
Prior art date
Application number
AT99905615T
Other languages
English (en)
Inventor
Roy Black
Raymond Paxton
Wolfram Bode
Klaus Maskos
Carlos Fernandez-Catalan
James Chen
Jeremy Levin
Original Assignee
Immunex Corp
Max Planck Inst For Biochemist
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immunex Corp, Max Planck Inst For Biochemist, Wyeth Corp filed Critical Immunex Corp
Application granted granted Critical
Publication of ATE366303T1 publication Critical patent/ATE366303T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6489—Metalloendopeptidases (3.4.24)

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Crystals, And After-Treatments Of Crystals (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT99905615T 1998-02-04 1999-02-03 Kristallines tnf-alpha-konvertierendes enzym und verwendung davon ATE366303T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US7370998P 1998-02-04 1998-02-04
US5008398A 1998-03-30 1998-03-30
US11747699P 1999-01-27 1999-01-27

Publications (1)

Publication Number Publication Date
ATE366303T1 true ATE366303T1 (de) 2007-07-15

Family

ID=27367666

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99905615T ATE366303T1 (de) 1998-02-04 1999-02-03 Kristallines tnf-alpha-konvertierendes enzym und verwendung davon

Country Status (15)

Country Link
EP (1) EP1053304B1 (de)
JP (1) JP2004503202A (de)
CN (1) CN1342200A (de)
AR (2) AR015513A1 (de)
AT (1) ATE366303T1 (de)
AU (1) AU2574099A (de)
CA (1) CA2319040A1 (de)
DE (1) DE69936445T2 (de)
DK (1) DK1053304T3 (de)
ES (1) ES2293718T3 (de)
HU (1) HUP0101596A1 (de)
IL (3) IL137557A0 (de)
NO (1) NO20003687L (de)
NZ (1) NZ505959A (de)
WO (1) WO1999040182A2 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6406901B1 (en) 1995-06-08 2002-06-18 Immunex Corporation TNF-a converting enzyme
WO2002033118A2 (en) * 2000-08-03 2002-04-25 The Texas A & M University System Isocitrate lyase enzyme from mycobacterium tuberculosis and inhibitory agents to combat persistent infection
US7138264B1 (en) 2002-05-24 2006-11-21 Schering Corporation Modified tumor necrosis factor-alpha converting enzyme and methods of use thereof
WO2005073400A2 (en) * 2004-01-26 2005-08-11 University Of Massachusetts Method of identifying amp- activated protein kinase (ampk) modulators and uses therefor
TWI516274B (zh) * 2013-11-27 2016-01-11 財團法人工業技術研究院 應用於生髮之方法及醫藥組成物

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5594106A (en) * 1993-08-23 1997-01-14 Immunex Corporation Inhibitors of TNF-α secretion
US5702935A (en) * 1994-04-28 1997-12-30 Albert Einstein College Of Medicine Of Yeshiva University, A Division Of Yeshiva University Method and compounds for inhibiting lipid biosynthesis of bacteria and plants
IL122305A0 (en) * 1995-06-08 1998-04-05 Immunex Corp Tace polypeptide its production and its use
WO1997008300A1 (en) * 1995-08-30 1997-03-06 Ariad Pharmaceuticals, Inc. Crystalline zap family proteins
WO1997015588A1 (en) * 1995-10-26 1997-05-01 St. Jude Children's Research Hospital Protective protein/cathepsin a and precursor: crystallization, x-ray diffraction, three-dimensional structure determination and rational drug design
JP2000507943A (ja) * 1996-03-26 2000-06-27 グラクソ、グループ、リミテッド 腫瘍壊死因子αコンバーターゼ

Also Published As

Publication number Publication date
AR015513A1 (es) 2001-05-02
AU2574099A (en) 1999-08-23
IL163513A (en) 2007-03-08
WO1999040182A2 (en) 1999-08-12
DE69936445T2 (de) 2008-04-10
CN1342200A (zh) 2002-03-27
JP2004503202A (ja) 2004-02-05
EP1053304A2 (de) 2000-11-22
HUP0101596A1 (hu) 2001-08-28
ES2293718T3 (es) 2008-03-16
WO1999040182A3 (en) 1999-10-07
NZ505959A (en) 2003-05-30
EP1053304B1 (de) 2007-07-04
CA2319040A1 (en) 1999-08-12
NO20003687L (no) 2000-09-19
DK1053304T3 (da) 2007-11-05
NO20003687D0 (no) 2000-07-18
IL163513A0 (en) 2005-12-18
IL137557A0 (en) 2001-07-24
DE69936445D1 (de) 2007-08-16
AR024804A1 (es) 2002-10-23

Similar Documents

Publication Publication Date Title
DE69911378D1 (de) Fluorierte ionomere und verwendung davon
EP1178542A4 (de) Solarzelle und solarzelleneinheit
DE10083288T1 (de) Dichtung und Rotationsanordnung zur Verwendung dieser Dichtung
GB0121314D0 (en) β-Secretase enzyme compositions and methods
DE69738197D1 (de) Azolotriazine und pyrimidine
DE60032247D1 (de) Fluorchemisches oligomer und seine verwendung
DE59903382D1 (de) Elektrolysezelle und deren Verwendung
NO20005100L (no) Genetisk modifiserte celler og fremgangsmåter for ekspresjon av rekombinant heparanase og fremgangsmåter for rensing av samme
DE59900872D1 (de) Speicherzellenanordnung und entsprechendes Herstellungsverfahren
DE69915066D1 (de) Biozide zusammensetzung und deren verwendung
ATE366811T1 (de) Heliomycin-kodierendes gen und seine verwendung
DE60035532D1 (de) Zentrifugationselement und Verwendung dieses Elements
DE69907802D1 (de) Thermisch wirkende Pflaster und seiner Verwendung
DE69937109D1 (de) Zahnbürste und herstellungsverfahren
DE59803426D1 (de) Speicherzellenanordnung und entsprechendes Herstellungsverfahren
IS5674A (is) Súkkinamíð latar fyrir interleukín-1ß umbreytingarensím (converting enzyme)
DE69916694D1 (de) 2-Hydroxy-5-methyl-hexan-3-on und 3-hydroxy-5-methyl-hexan-2-on
DE50008549D1 (de) Triazolotriazinone und ihre verwendung
ATE353367T1 (de) Group b streptococcus proteine und deren verwendung
DE69909361D1 (de) Süssmittelzusammensetzung und Verwendung
DE69917777D1 (de) Benzazol-verbindungen und ihre verwendung
DE69936445D1 (de) Kristallines tnf-alpha-konvertierendes enzym und verwendung davon
DE60005514D1 (de) Dormanz-brechende zusammenstezung und deren verwendung
DE69940533D1 (de) Leistungsverstärker mit sanfter Umschaltung und Mehrpegel-Schaltzellen
DE60036885D1 (de) Succinimidverbindungen und deren verwendung

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties